NCT03906045View on ClinicalTrials.gov

A Scintigraphy Study of PT010 in COPD Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

March 5, 2020

Study Completion Date

March 5, 2020

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

BGF-MDI

Budesonide, Glycopyrronium and Formoterol Fumarate.

Trial Locations (2)

SA14 8QF

Research Site, Llanelli

CF48 4DR

Research Site, Merthyr Tydfil

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Simbec Research

INDUSTRY

lead

AstraZeneca

INDUSTRY